Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros







Tipo de estudo
Intervalo de ano
1.
Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia
Khurshid Ahmed, Khan; Ayesha, Junaid; Nauman Saleem, Siddiqui; Khalida, Mukhtar; Saleem, Siddiqui.
JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 2008; 18 (3): 176-178
em Inglês | IMEMR | ID: emr-100294

RESUMO

Imatinib mesylate is a BCR-ABL tyrosine kinase inhibitor used in the management of chronic myeloid leukemia. It is a safe and well-tolerated agent with a few manageable side effects. We are reporting a case of imatinib-related fatal bone marrow aplasia after complete cytogenetic response


Assuntos
Humanos , Masculino , Pirimidinas/efeitos adversos , Piperazinas/efeitos adversos , Proteínas Tirosina Quinases/antagonistas & inibidores , Leucemia Mielogênica Crônica BCR-ABL Positiva/tratamento farmacológico
ENVIAR RESULTADO:
Email
Exportar
Imprimir
RSS
XML
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA